Combinatorial Treatment of "Armed" Oncolytic Adenovirus Expressing Checkpoint Inhibitor and Cytokine with Chimeric Antigen Receptor T-Cells Leads to Superior Anti-Tumor Effects in Head and Neck Cancer

被引:0
|
作者
Shaw, Amanda Rosewell [1 ]
Porter, Caroline [1 ]
Watanabe, Norihiro [1 ]
Tanoue, Kiyonori [1 ]
Brenner, Malcolm [1 ]
Suzuki, Masataka [1 ]
机构
[1] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
12
引用
收藏
页码:6 / 7
页数:2
相关论文
共 28 条
  • [1] Combined Mesothelin-Redirected Chimeric Antigen Receptor T Cells with Cytokine-Armed Oncolytic Adenoviruses for the Treatment of Pancreatic Cancer
    Watanabe, Keisuke
    Luo, Yanping
    Da, Tong
    Guedan, Sonia
    Ruella, Marco
    Scholler, John
    Keith, Brian
    Young, Regina M.
    Engels, Boris
    Sorsa, Suvi
    Siurala, Mikko
    Havunen, Riikka
    Tahtinen, Siri
    Carrascon, Victor
    Hemminki, Akseli
    June, Carl H.
    MOLECULAR THERAPY, 2018, 26 (05) : 7 - 8
  • [2] Armed-Ad Gene Therapy Expressing PD-L1 Minibody Enhances the Anti-Tumor Effect of Adoptively Transferred Chimeric Antigen Receptor T-Cells for Solid Tumor Treatment
    Shaw, Amanda Rosewell
    Tanoue, Kiyonori
    Watanabe, Norihiro
    Porter, Caroline
    Brenner, Malcolm
    Suzuki, Masataka
    MOLECULAR THERAPY, 2016, 24 : S204 - S205
  • [3] Targeting the extended erbb receptor family using chimeric antigen receptor (CAR)-grafted t-cells as a treatment for head and neck cancer
    Davies, David M.
    Wilkie, Scott
    Foster, Julie M.
    Delinassios, George
    Chiapero-Stanke, Laura
    Burbridge, Sophie
    Mather, Stephen J.
    Eccles, Suzanne A.
    Maher, John
    CANCER RESEARCH, 2010, 70
  • [4] Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses
    Watanabe, Keisuke
    Luo, Yanping
    Da, Tong
    Guedan, Sonia
    Ruella, Marco
    Scholler, John
    Keith, Brian
    Young, Regina M.
    Engels, Boris
    Sorsa, Suvi
    Siurala, Mikko
    Havunen, Riikka
    Tahtinen, Siri
    Hemminki, Akseli
    June, Carl H.
    JCI INSIGHT, 2018, 3 (07)
  • [5] Armed Oncolytic Adenovirus-Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid Tumors
    Tanoue, Kiyonori
    Shaw, Amanda Rosewell
    Watanabe, Norihiro
    Porter, Caroline
    Rana, Bhakti
    Gottschalk, Stephen
    Brenner, Malcolm
    Suzuki, Masataka
    CANCER RESEARCH, 2017, 77 (08) : 2040 - 2051
  • [6] Enhancing the anti-tumor efficacy of chimeric antigen receptor-expressing T cells with naturally occuring plant stilbenes
    Soles, Andrea
    Richardson, Elle
    Barber, Amorette
    FASEB JOURNAL, 2019, 33
  • [7] Oncolytic adenovirus targeting TGF-β enhances anti-tumor responses of mesothelin-targeted chimeric antigen receptor T cell therapy against breast cancer
    Li, Yuxiang
    Xiao, Fengjun
    Zhang, Aimei
    Zhang, Dan
    Nie, Wenbo
    Xu, Tianxin
    Han, Bing
    Seth, Prem
    Wang, Hua
    Yang, Yuefeng
    Wang, Lisheng
    CELLULAR IMMUNOLOGY, 2020, 348
  • [8] High affinity NK cells expressing a PD-L1 chimeric antigen receptor demonstrate anti-tumor activity in head and neck cancer through multiple distinct mechanisms
    Robbins, Yevtte
    Friedman, Jay
    Greene, Sarah
    Fabian, Kellsye
    Padget, Michelle
    Lee, John
    Soon-Shiong, Patrick
    Niazi, Kayvan
    Sender, Lennie
    Boissel, Laurent
    Schlom, Jeffrey
    Hodge, James
    Allen, Clint
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [9] Construction of chimeric antigen receptor-modified T cells targeting EpCAM and assessment of their anti-tumor effect on cancer cells
    Zhou, Yan
    Wen, Ping
    Li, Mingmei
    Li, Yaqi
    Li, Xiao-An
    MOLECULAR MEDICINE REPORTS, 2019, 20 (03) : 2355 - 2364
  • [10] A novel AXL chimeric antigen receptor endows T cells with anti-tumor effects against triple negative breast cancers
    Wei, Jing
    Sun, Huiyan
    Zhang, Aimei
    Wu, Xuejie
    Li, Yuxiang
    Liu, Jiawei
    Duan, Yanting
    Xiao, Fengjun
    Wang, Hua
    Lv, Ming
    Wang, Lisheng
    Wu, Chutse
    CELLULAR IMMUNOLOGY, 2018, 331 : 49 - 58